Stolen HIV/AIDS Goat Serum Treatment Located
The experimental HIV/AIDS drug made from goat serum that was allegedly stolen from its sponsor's storage facility is in the possession of a Raleigh/Durham, N.C., man who heads Immuno Therapeutic International Inc. The drug's sponsor, Dr. Gary Davis, had written a letter to the FDA "assert[ing]" that 80 liters of the product was "in the possession" of Steve Migliaccio of Immuno Therapeutic. Migliaccio acknowledged in a Dec. 23 interview with the Raleigh News & Observer that he had possession of the serum and said "he owns the material under a multimillion-dollar contract" that Immuno Therapeutic maintains with Davis. Migliaccio said, "We have an exclusive contract giving us intellectual property rights, patents and the right to conduct clinical trails and to distribute the medicine if it's approved by the FDA." He also said that Davis struck a business deal three months ago with London investment group Valentine Strategic Investments Limited, but the company disputed Migliaccio's statement. In addition, Migliaccio said his company is conducting human trials with the serum in Matamoros, Mexico, with 15 U.S. citizens, but the FDA said that the serum "has not been approved for clinical trials on humans and is dangerous." Furthermore, Dr. Myron Cohen, director of the University of North Carolina at Chapel Hill's Center for Infectious Diseases said on Dec. 23 that "he never heard of Davis or the drug he claims to be testing." Cohen said, "There's no possibility that it's something earthshaking. We would know about that" (Medical Letter on the CDC & FDA/NewsRX.com, 1/21).This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.